2-Methyl-5,7,8-Trimethoxyisoflavone

2-Methyl-5,7,8-Trimethoxyisoflavone

SCHEMBL4283593

COc1cc(OC)c2c(=O)c(-c3ccccc3)c(C)oc2c1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 1.00
▸ CYP3A4 P08684 1/20 1.00
▸ BCL9 O00512 4/20 0.56
▸ CTNNB1 P35222 4/20 0.56
▸ ACHE P22303 1/20 0.54
▸ PLK1 P53350 1/20 0.54
▸ BACE1 P56817 1/20 0.54
▸ ALOX5 P09917 2/20 0.51
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ ABCB1 P08183 1/20 0.47
▸ ABCG2 Q9UNQ0 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ MGAM O43451 1/20 0.46
▸ GABRP O00591 1/20 0.44
▸ GABRD O14764 1/20 0.44
▸ KDM1A O60341 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31065460 0.81 ALDH1A1 (0.68) ALDH1A1CYP3A4BCL9CTNNB1ACHE
SCHEMBL1628395 0.80 ALDH1A1 (0.67) ALDH1A1CYP3A4BCL9CTNNB1CYP1A2
SCHEMBL28011841 0.78 ACHE (0.79) ALDH1A1CYP3A4ACHEPLK1BACE1
SCHEMBL31619650 0.73 KDM4E (0.59) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL8983906 0.71 KDM4E (0.56) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL737207 0.71 ADORA3 (0.58) ALDH1A1CYP3A4ALOX5CYP2C9CYP2C19
SCHEMBL4287360 0.71 ALDH1A1 (0.55) ALDH1A1CYP3A4ALOX5ABCB1ABCG2
SCHEMBL5951260 0.71 PDE4B (0.59) ALDH1A1CYP3A4BCL9CTNNB1MEN1
SCHEMBL16894627 0.71 ADORA3 (0.64) ALDH1A1CYP3A4BCL9CTNNB1ALOX5
Moslosooflavone SCHEMBL6070206 0.70 ACHE (1.00) ALDH1A1CYP3A4ACHEPLK1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143279-A1 Methods and compositions for treating metabolic disorders PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2009-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143279-A1 Methods and compositions for treating metabolic disorders PC, PCK2, CS ALDH1A1 860/4885CYP3A4 2876/4885BCL9 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback